IPO Listed

Suzhou Ribo Life Science Co. IPO

HK$1.8bn raised

HKEX: 6938

Advisers

Lead managers

Joint lead manager
CICC (co) (as China International Capital Corporation Hong Kong Securities)
Citi (co)
Issuer
Suzhou Ribo Life Science Co.
Issuer based in
China
Listed
Jan 2026
Sector
Biotech
Tags
Biotech, Drug Development, Pharma

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.